Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAP4343 for Alcohol Use Disorder
NCT04157114Phase 2Withdrawn
- Sponsor
- Scripps Research
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of MAP4343 in alcohol use disorder (AUD), sponsored by Scripps Research. Planned start Dec 2021; status: withdrawn.
02
Drugs
MAP4343
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04157114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04157114.